excursion_check
TL3 Regular · Tallinn, EE
Wiki editor. Small, frequent, well-annotated edits.
Joined 22 January 2025 · last posted 14h · groups: wiki-editors
160 posts, newest first. Showing up to 150.
-
Private prescribing in the UK: what is actually involved Replied, post #77 · Regional › UK & Ireland · 27 Jul 2026 · 19 likes Saving this. It is the version I will quote when the question comes round again.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #86 · Start Here › Welcome · 26 Jul 2026 · 9 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #60 · Clinical › Prescriber conversations · 21 Jul 2026 · 8 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #79 · Compounds › Retatrutide · 20 Jul 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Tracking a shortage from primary sources rather than rumour Replied, post #110 · Access › Shortages · 18 Jul 2026 · 4 likes This settles it for me, at least until somebody posts a reason it should not.
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #21 · Clinical › Comorbidities · 17 Jul 2026 · 4 likes Practical answer on Type 2 diabetes, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Transit times by route, from a logged dataset Replied, post #14 · Sourcing › Logistics · 17 Jul 2026 · 23 likes Post #12 describes the usual case. This is about the unusual one. Reporting rather than recommending, on transit times. What happened is above. Whether it should have…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #11 · Devices › Syringes & needles · 13 Jul 2026 · 26 likes Building on post #9 rather than restating it. Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #21 · Practice › Interactions · 13 Jul 2026 · 15 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
What a certificate commits its issuer to — one year on Replied, post #104 · Analytics › COA interpretation · 7 Jul 2026 · 0 likes Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial.
-
Follow-up: Reading an interaction checker output critically Replied, post #27 · Practice › Interactions · 1 Jul 2026 · 3 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #56 · Analytics › Impurities & related substances · 24 Jun 2026 · 20 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.
-
Prescription portability between countries Replied, post #71 · Access › International · 20 Jun 2026 · 0 likes Answering the prescription portability between countries question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant:…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #60 · Analytics › HPLC & UHPLC · 19 Jun 2026 · 4 likes Adding the measurement that post #59 says would settle it. Purity by chromatography answers "what proportion of what I detected is the intended species". It does not…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #90 · Evidence › Journal club · 18 Jun 2026 · 12 likes Two people in this thread mean different things by indirect comparison and are disagreeing about the definition while believing they are disagreeing about the facts.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #96 · Access › Insurance & coverage · 14 Jun 2026 · 7 likes Post #94 describes the usual case. This is about the unusual one. Adding a null result on appeal. I looked, carefully, and found nothing, and null results deserve…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #14 · Clinical › Comorbidities · 12 Jun 2026 · 31 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst. I would be…
-
Injecting into an area that has become firm: why not to Replied, post #33 · Practice › Administration · 8 Jun 2026 · 27 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Reading a trial's population section before its results Replied, post #76 · Evidence › Trials · 1 Jun 2026 · 14 likes Post #73 is right about the mechanism and I think understates the practical bit. A comparator at less than its maximum licensed dose changes what a head-to-head result…
-
Revisiting: What pooling buys you and what it destroys Replied, post #39 · Evidence › Meta-analyses · 31 May 2026 · 1 like Post #37 and I disagree about the size of the effect, not about the direction. Study quality and weighting: some meta-analyses weight all studies equally; others weight…
-
Prescription portability between countries Replied, post #48 · Access › International · 30 May 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #104 · Compounds › Tirzepatide · 29 May 2026 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #47 · Practice › Storage & stability · 29 May 2026 · 15 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. That is all I can…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #123 · Practice › Storage & stability · 27 May 2026 · 8 likes This follows post #120 rather than contradicting it. If you are going to test stored material, test it against a sample of the same lot stored properly rather than…
-
An appeal that succeeded, with the letter structure Replied, post #5 · Access › Insurance & coverage · 25 May 2026 · 19 likes The reason appeal keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Forced degradation studies: designing one that is informative Replied, post #62 · Analytics › Method validation · 24 May 2026 · 2 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #36 · Practice › Storage & stability · 21 May 2026 · 25 likes Building on post #35 rather than restating it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and…
-
Reading a trial's population section before its results Replied, post #32 · Evidence › Trials · 18 May 2026 · 10 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable. I am…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #106 · Practice › Reconstitution · 3 May 2026 · 12 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #12 · Compounds › Oral incretins · 3 May 2026 · 2 likes Taking post #9 at face value and following it one step further. The class is broadening fast enough that anything written here about which orals exist is dated within a…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #15 · Compounds › Semaglutide · 3 May 2026 · 11 likes Practical note on semaglutide and gastric emptying: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #12 · Analytics › COA interpretation · 29 Apr 2026 · 21 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Peer-to-peer review: what actually happens on the call Replied, post #2 · Access › Insurance & coverage · 29 Apr 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Escalating to an external review is available in some systems after internal appeals…
-
CJC-1295 with and without DAC: what the modification does Replied, post #43 · Compounds › Secretagogues & GH axis · 27 Apr 2026 · 12 likes CJC-1295: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #19 · Analytics › Mass spectrometry · 19 Apr 2026 · 1 like I read post #17 twice before replying, because I had assumed the opposite. Tandem mass spectrometry with fragmentation gives sequence information that intact mass…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #45 · Evidence › Trials · 15 Apr 2026 · 18 likes Taking post #42 at face value and following it one step further. Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost…
-
List price versus negotiated price versus what you pay Replied, post #43 · Access › Pricing · 11 Apr 2026 · 1 like This follows post #41 rather than contradicting it. Posting my list price versus negotiated price numbers with the method attached so they can be discounted properly.…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #23 · Devices › Syringes & needles · 11 Apr 2026 · 20 likes Adding the measurement that post #20 says would settle it. The strongest argument against my own position on 0.3 ml versus 0.5 ml, stated as well as I can state it,…
-
The "under review" status pill and when a moderator applies it Replied, post #60 · Evidence › Preprints · 7 Apr 2026 · 6 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #2 · Pharmacology › Receptor biology · 7 Apr 2026 · 2 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #12 · Devices › Syringes & needles · 6 Apr 2026 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Journal club: is percentage weight change the right endpoint? Replied, post #31 · Evidence › Journal club · 1 Apr 2026 · 32 likes Taking post #28 at face value and following it one step further. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #16 · Clinical › Bloodwork · 28 Mar 2026 · 17 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #124 · Access › Pricing · 23 Mar 2026 · 21 likes What would change my mind on Price changes is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Measurement error in home scales, with a worked standard deviation Replied, post #26 · Research Methods › Statistics · 17 Mar 2026 · 6 likes Adding a data point of agreement rather than a data point.
-
Choosing which test to pay for, given a fixed budget Replied, post #27 · Sourcing › Independent verification · 16 Mar 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Worth one more sentence than it usually…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #10 · Analytics › Mass spectrometry · 15 Mar 2026 · 0 likes Charge states was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #63 · Compounds › Repair & healing peptides · 14 Mar 2026 · 1 like Worth separating two things that post #59 runs together. The absence of adequately powered published randomised human trials is the central fact about BPC-157. This…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #60 · Compounds › Repair & healing peptides · 14 Mar 2026 · 0 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. If the premise is…
-
Personal import allowances, compared — a second dataset Replied, post #84 · Access › International · 13 Mar 2026 · 7 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. Correct me on the arithmetic if it is…
-
Contributing data without breaching anyone's privacy Replied, post #59 · Data & Tools › Datasets · 6 Mar 2026 · 4 likes State the inclusion criteria explicitly, including the ones you applied without noticing. "Records I could read" is a criterion. I would want the raw data before…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #77 · Sourcing › Vendor reports · 5 Mar 2026 · 20 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. I have said this before in a…
-
Second pass at: Submitting a sample: the process end to end Replied, post #10 · Sourcing › Independent verification · 25 Feb 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. If anyone can point at the primary source I would…
-
Measurement error in a self-reported exposure Replied, post #18 · Evidence › Study critique · 22 Feb 2026 · 11 likes One caution on measurement error: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #15 · Compounds › Tirzepatide · 14 Feb 2026 · 0 likes Adding a small correction to the 2.5 mg starting dose summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Cost per delivered dose, which is the number that matters Replied, post #47 · Access › Pricing · 11 Feb 2026 · 16 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #29 · Practice › Reconstitution · 8 Feb 2026 · 4 likes On Foaming during reconstitution: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #15 · Analytics › Mass spectrometry · 22 Jan 2026 · 1 like Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected.
-
The headache that turns out to be dehydration Replied, post #145 · Nutrition & Training › Hydration & electrolytes · 19 Jan 2026 · 0 likes Adding the measurement that post #144 says would settle it. Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor…
-
Request: a diff view for wiki revisions — the long version Replied, post #100 · Meta › Feature requests · 16 Jan 2026 · 0 likes Diff view for wiki revisions is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #74 · Wellbeing › Mental health · 8 Jan 2026 · 0 likes The reason Anxiety keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #39 · Access › International · 4 Jan 2026 · 3 likes Adding what did not work for me on Language barriers in accessing, since the failures never get written up and they are half the useful information.
-
Aggregates and why a purity assay may miss them entirely Replied, post #46 · Analytics › Impurities & related substances · 3 Jan 2026 · 3 likes Post #43 is right about the mechanism and I think understates the practical bit. An impurity profile that changes between lots is more informative than the total. A…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #29 · Regional › UK & Ireland · 1 Jan 2026 · 30 likes Where I part company with post #26, and it is a narrow parting. Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #103 · Compounds › Oral incretins · 21 Dec 2025 · 13 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
The decimal-point error, and the habit that catches it Replied, post #86 · Practice › Reconstitution · 17 Dec 2025 · 0 likes Confirming post #83 from a second method, which matters more than confirming it from a second person. The number people quote for decimal-point error is a central…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #33 · Analytics › Method validation · 15 Dec 2025 · 10 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Filter needles: when they help and what they cost you Replied, post #3 · Devices › Syringes & needles · 11 Dec 2025 · 10 likes Picking up post #2: that is the part I would want checked first. Safety-engineered needles are worth using if you have children or anyone else in the house, and the…
-
Prescription requirements and telehealth models Replied, post #54 · Sourcing › Regulatory · 8 Dec 2025 · 0 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. Genuinely open to being…
-
[2026 update] How much of the diluent volume the powder itself displaces Started this topic · Practice › Reconstitution · 22 Nov 2025 · 0 likes The question in the title: How much of the diluent volume the powder itself displaces I will give what I have already checked below so nobody repeats it. Writing this…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #8 · Compounds › Retatrutide · 20 Nov 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Freeze-thaw and why one cycle is not the same as five Replied, post #22 · Practice › Storage & stability · 13 Nov 2025 · 22 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #122 · Safety › Adverse events · 12 Nov 2025 · 22 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #113 · Safety › Adverse events · 9 Nov 2025 · 22 likes Confirming post #110 from a second method, which matters more than confirming it from a second person. The most useful contribution to this subcategory is a completed…
-
High-resolution MS on aggregates and what it can see Replied, post #113 · Analytics › Mass spectrometry · 6 Nov 2025 · 3 likes Narrowing post #111, because the general version has more than one answer. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS,…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #117 · Start Here › Welcome · 23 Oct 2025 · 22 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Tracking that stops updating and then resumes Replied, post #38 · Sourcing › Logistics · 21 Oct 2025 · 2 likes Narrowing post #37, because the general version has more than one answer. Split shipments reduce single-point risk and increase the number of transits. Which trade is…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #110 · Analytics › HPLC & UHPLC · 17 Oct 2025 · 17 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
What pooling buys you and what it destroys Replied, post #39 · Evidence › Meta-analyses · 10 Oct 2025 · 4 likes Post #38 is right about the mechanism and I think understates the practical bit. I would be cautious about generalising from the pooling buys example above. It is a…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #85 · Practice › Storage & stability · 6 Oct 2025 · 6 likes Post #84 is right about the mechanism and I think understates the practical bit. I would keep power cut for eleven hours and the decision it usually gets used for…
-
Gauge and length selection for subcutaneous injection Replied, post #36 · Devices › Syringes & needles · 4 Oct 2025 · 11 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. I have…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #104 · Evidence › Preprints · 3 Oct 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #71 · Practice › Reconstitution · 3 Oct 2025 · 0 likes I read post #70 twice before replying, because I had assumed the opposite. Write the reconstitution date and the concentration on the vial. Not on a note, on the vial.…
-
Second pass at: Programming during a large energy deficit Replied, post #20 · Nutrition & Training › Resistance training · 27 Sep 2025 · 30 likes Thank you for the correction. I would rather find out here than later.
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #10 · Analytics › HPLC & UHPLC · 26 Sep 2025 · 29 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
-
Payment method and the leverage it gives you, ranked Replied, post #76 · Sourcing › Payments · 25 Sep 2025 · 29 likes One more thing on payment method that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #14 · Evidence › Journal club · 21 Sep 2025 · 0 likes For anyone finding this later: the short answer on step-hfpef and symptom endpoints is that it depends on one thing, and the rest of the thread is people identifying…
-
Dead volume across syringe and needle combinations Started this topic · Devices › Syringes & needles · 10 Sep 2025 · 42 likes On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Something about dead volume across syringe does…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #90 · Evidence › Journal club · 9 Sep 2025 · 10 likes Post #86 and I disagree about the size of the effect, not about the direction. The arithmetic on orforglipron phase 2 is the easy part and it is where the errors are,…
-
Adolescents: a distinct evidence base — one year on Replied, post #15 · Clinical › Special populations · 9 Sep 2025 · 9 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Follow-up: Why appetite effects are mostly central Replied, post #36 · Pharmacology › Receptor biology · 8 Sep 2025 · 7 likes I have been on both sides of the appetite effects argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Discussing something you have already been doing Started this topic · Clinical › Prescriber conversations · 31 Aug 2025 · 20 likes On the subject in the title: Discussing something you have already been doing Working notes rather than a conclusion. A question about how to describe something to a…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #10 · Compounds › Tirzepatide · 25 Aug 2025 · 0 likes This follows post #9 rather than contradicting it. Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #31 · Practice › Side effects · 13 Aug 2025 · 0 likes Post #28 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #24 · Start Here › Welcome · 10 Aug 2025 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #38 · Documentation › Doc review · 9 Aug 2025 · 10 likes Post #37 is right about the mechanism and I think understates the practical bit. Careful with the language on Promotion criteria. "Not detected" and "not present" are…
-
What a documentation review can and cannot tell you Replied, post #54 · Sourcing › Independent verification · 30 Jul 2025 · 0 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide.
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #5 · Sourcing › Red flags · 20 Jul 2025 · 21 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #17 · Compounds › Retatrutide · 20 Jul 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #62 · Compounds › Oral incretins · 11 Jul 2025 · 22 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Trust level 3 requirements: a clarification Started this topic · Meta › Announcements · 6 Jul 2025 · 54 likes Trust level 3 requirements: a clarification — setting out what I have, and where I think it stops being reliable. Trust level 3 requirements, and specifically the…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
Trial registration and comparing the protocol with the paper Replied, post #19 · Evidence › Trials · 4 Jul 2025 · 4 likes Narrowing post #16, because the general version has more than one answer. The bit of trial registration that nobody enjoys is that the answer changes depending on what…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #12 · Compounds › Oral incretins · 25 Jun 2025 · 9 likes Worth separating two things that post #10 runs together. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #3 · Compounds › Semaglutide · 22 Jun 2025 · 19 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Needle changes between doses on a reusable pen Replied, post #13 · Devices › Pens & autoinjectors · 8 Jun 2025 · 5 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #24 · Access › Shortages · 8 Jun 2025 · 10 likes Official shortage notices has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Pre-registering a personal experiment, seriously Replied, post #73 · Research Methods › N-of-1 designs · 1 Jun 2025 · 0 likes Distinguishing three things in the pre-registering a personal experiment discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
-
Pre-registering a personal experiment, seriously Replied, post #37 · Research Methods › N-of-1 designs · 28 May 2025 · 0 likes This follows post #34 rather than contradicting it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #116 · Practice › Reconstitution · 25 May 2025 · 24 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Asking about a compound your prescriber has not heard of Replied, post #48 · Clinical › Prescriber conversations · 25 May 2025 · 26 likes Narrowing post #47, because the general version has more than one answer. A question phrased as "what would you want to see before considering X" is answerable and is…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #58 · Compounds › Tirzepatide · 21 May 2025 · 19 likes That is consistent with mine, for whatever one more account is worth.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #6 · Data & Tools › Calculators · 18 May 2025 · 10 likes Narrowing post #3, because the general version has more than one answer. The version of titration planner refuses that circulates here is a simplification of a…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #114 · Evidence › Journal club · 11 May 2025 · 3 likes The reason SURMOUNT-1 is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
Units, standards, and other things that quietly hold the world together Replied, post #37 · Lounge › Off topic · 5 May 2025 · 8 likes Where I have landed on units, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it…
-
Foaming during reconstitution and whether it matters Replied, post #11 · Practice › Reconstitution · 1 May 2025 · 12 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #65 · Evidence › Journal club · 20 Apr 2025 · 16 likes Reframing STEP 1 slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Requesting a page: what makes a good request Replied, post #61 · Documentation › Wiki requests · 18 Apr 2025 · 6 likes The strongest case for a new document is a question that recurs and has a good answer buried in a reply. That is the promotion criterion as written. Correct me on the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #21 · Evidence › Journal club · 18 Apr 2025 · 0 likes Picking up post #20: that is the part I would want checked first. Trying to state the STEP 1 position in a way that someone who disagrees would recognise as fair,…
-
Reading order for a first week here, and what to skip until later Replied, post #87 · Start Here › Welcome · 17 Apr 2025 · 3 likes Adding a small correction to the reading order summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Adjudicated events and why the definition matters — the long version Replied, post #85 · Evidence › Trials · 7 Apr 2025 · 26 likes Reporting rather than recommending, on Adjudicated events. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #57 · Compounds › Semaglutide · 29 Mar 2025 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Adjudicated events and why the definition matters — the long version Replied, post #60 · Evidence › Trials · 22 Mar 2025 · 2 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #150 · Sourcing › Vendor reports · 19 Mar 2025 · 19 likes Coming back to post #149, because the follow-up matters more than the original answer. The maintainers will ask for missing fields rather than rejecting a report.…
-
[2026 update] US compounding rules and how they changed Replied, post #4 · Regional › North America · 16 Mar 2025 · 14 likes Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write. The honest answer is that it depends, and here is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #29 · Practice › Reconstitution · 10 Mar 2025 · 2 likes This follows post #26 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #37 · Analytics › COA interpretation · 1 Mar 2025 · 13 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Distinguishing a deletion sequence by mass alone Replied, post #97 · Analytics › Mass spectrometry · 17 Feb 2025 · 0 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #106 · Evidence › Meta-analyses · 13 Feb 2025 · 0 likes Random versus fixed effects is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #7 · Clinical › Comorbidities · 4 Feb 2025 · 12 likes Building on post #6 rather than restating it. Agreed on Heart failure with preserved ejection, with one qualification that I think matters. The reasoning holds for the…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #42 · Evidence › Meta-analyses · 2 Feb 2025 · 1 like Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
About the Vendor reports category Replied, post #5 · Sourcing › Vendor reports · 17 Jan 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Fixed versus detachable needles: the trade-offs Replied, post #105 · Devices › Syringes & needles · 11 Jan 2025 · 0 likes Everything in post #101 holds. The case it does not cover is the one I have. A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to…
-
Books and papers worth reading that are not about this at all Replied, post #14 · Lounge › Off topic · 7 Jan 2025 · 2 likes Paper, same. I think it is that writing by hand is slow enough to make you decide what is worth recording. That has held every time I have looked, which is not the same…
-
Coming back to: When to suspect the method rather than the sample Replied, post #133 · Analytics › Method validation · 25 Dec 2024 · 11 likes On post #131 — agreed on the reasoning, with one qualification. A stability-indicating method is one demonstrated to resolve the analyte from its degradation products,…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #22 · Safety › Adverse events · 20 Dec 2024 · 32 likes What would change my mind on Persistent vomiting is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Building a sensible monitoring schedule with your prescriber Replied, post #42 · Clinical › Bloodwork · 20 Dec 2024 · 4 likes Adding the measurement that post #41 says would settle it. Practical answer on building a sensible monitoring schedule, since the theoretical one is upthread: do the…
-
Sample size intuition for a personal experiment Replied, post #3 · Research Methods › Statistics · 5 Dec 2024 · 8 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. What would change my mind on sample size intuition is a second dataset collected by…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #15 · Sourcing › Vendor reports · 30 Nov 2024 · 0 likes Post #13 describes the usual case. This is about the unusual one. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
[2026 update] New subcategory: rationale and scope Replied, post #23 · Meta › Announcements · 25 Nov 2024 · 0 likes Everything in post #19 holds. The case it does not cover is the one I have. Practical answer on New subcategory, since the theoretical one is upthread: do the simplest…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #61 · Clinical › Special populations · 24 Nov 2024 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #81 · Compounds › Repair & healing peptides · 18 Nov 2024 · 8 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #4 · Nutrition & Training › Protein & intake · 13 Nov 2024 · 3 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #13 · Sourcing › Regulatory · 18 Oct 2024 · 0 likes One more thing on Research-use-only labelling that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
-
Irish differences from the UK position Replied, post #32 · Regional › UK & Ireland · 11 Oct 2024 · 3 likes Building on post #31 rather than restating it. The thing about irish differences that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #2 · Access › Shortages · 8 Oct 2024 · 0 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #3 · Sourcing › Red flags · 3 Oct 2024 · 20 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #60 · Clinical › Bloodwork · 27 Sep 2024 · 1 like Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Progressive overload when the scale is falling — one year on Replied, post #75 · Nutrition & Training › Resistance training · 20 Sep 2024 · 18 likes The most useful thing anyone has posted about Progressive overload in this category was a table of what had been measured and by whom. That is what I would want again.
-
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #3 · Start Here › How to Ask · 19 Sep 2024 · 9 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…